Articles On Respiri (ASX:RSH)

Special Report: Respiratory ehealth business Respiri (ASX:RSH) has signed a deal to educate Australia’s pharmacists on how to further help patients with asthma — and get its wheezo app out there in the process. Respiri has signed a definiti...

Respiri (ASX: RSH) has collared a two-year definitive service agreement with the Pharmacy Guild of Australia to develop an online pharmacist course on optimising asthma patient management including the role of devices such as Respiri’s whee...

Participating in small cap raises is proving lucrative for investors, with shares in 47 small caps that tapped equity markets in April currently trading higher than the price at which they raised cash. Stockhead counted at least 66 offers i...

Respiri (ASX: RSH) has topped up its cash reserves with $3.14 million after receiving “significant oversubscriptions” in a recent share purchase plan. The company launched the share purchase plan last month, with the original offer to raise...

Special Report: eHealth SaaS company Respiri has raised $3.14m in a heavily oversubscribed capital raising, taking its total funds raised to $5.2m   Respiri (ASX:RSH) has closed an oversubscribed share purchase plan, raising $3.14m after he...

As we approach the middle of 2020, the investment environment surrounding the fallout from the COVID-19 pandemic remains complex. Along with threats, there will be plenty of opportunities. And it’s against that backdrop that this week marke...

VidCon is Stockhead’s new virtual conference series, bringing you expert insights, panel discussions and presentations on the most interesting and relevant investment sectors from leading analysts, listed small caps and industry participant...

It’s still a relatively difficult market to raise capital in, particularly at the junior end, but there are some that have convinced investors to part with their hard earned cash. We run through just which small and micro caps successfully...

Special Report: The deal with telehealth platform Practice Innovators International will give Respiri more exposure to a fast-growing sector. Software as a Service (SaaS) health tech company Respiri (ASX:RSH) has scored a key distribution d...

Respiratory health management company Respiri (ASX: RSH) has entered into commercial discussions with Australian start-up Practice Innovators International Pte Ltd with a view to launching an integrated telehealth service for asthma patient...

Shares in Respiri Limited (ASX:RSH), an eHealth SaaS company supporting respiratory health management, hit a high of 11.5 cents on Tuesday, representing a 55% rise relative to its previous closing price of 7.4 cents. The sharp uptick in the...

Respiri (ASX: RSH) has expanded the market for its wheezo technology after announcing a partnership with Phenix Health. The parties have inked a joint development agreement which will involve integrating Respiri’s wheezo eHealth software as...

Australian biotech Genetic Signatures’ (ASX:GSS) is now able to start selling its recently developed COVID-19 diagnostic kit, after it was approved for sale in Australia. The EasyScreen SARS-CoV-2 Detection Kit has been approved to be liste...

Stock Talk is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this first edition, host Dr Nigel Finch examines the coronavirus-induced boom of the telehealth industry. Populatin...

Despite March being a tough month to raise capital for ASX small caps, the money was still flowing for the gold explorers. In March, ASX small caps raised $72.2m, a steep decline from the $125m raised in February. Even in January, tradition...

The COVID-19 pandemic is making capital harder to come by for businesses across the board. But listed health-tech platform Respiri (ASX:RSH) still managed to close the deal, announcing the completion of its $2m share placement yesterday. Am...

The coronavirus-induced market carnage of the last few weeks has rattled plenty of investor nerves. But as with any major correction, some industries feel the brunt of the impact while for others, the dramatic shift presents an opportunity....

Respiratory focused SaaS company Respiri Limited (ASX: RSH) has experienced inbound demand for its world class wheezo technology from three Chinese hospitals relating to monitoring patients with coronavirus COVID19. According to Respiri, wh...

Jatenergy (ASX:JAT) shares are surging after the company said it booked record sales and revenue in February, as Chinese buyers sucked up its milk products. Revenue was $8.3m for the month. The board has lifted full year guidance from $36m...

Investment bank Lazard believes shareholder activism is going to become more rife in future. Shareholder activism occurs when existing shareholders publically attempt to influence a company’s behaviour. To meet the criteria they have to be...

Healthcare technology developer Respiri (ASX: RSH) has revealed that the company has received the highly coveted CE Mark and TGA approval to list its Wheezo product on the Australian Therapeutics Goods Register (ARTG). Respiri is marketing...

Air pollution is a growing problem that in recent days has reached our own backyard. Because of the bushfires in surrounding areas, Sydney’s air has been ranked the ninth worst in the world. It’s not the first time in history it’s happened...

We hate to sound like an old school report, but it’s been a year of steady and solid progress for the maker of non-invasive cardiac and pulmonary measuring devices, especially in its key target market of China. Achievements include record r...

James Dean is returning to the silver screens after a six and a half decade absence. The Rebel Without A Cause star passed away in a car crash in 1955 but he will be starring in the Vietnam War era drama Finding Jack. Of course filmmakers a...

In a submission to the aged care royal commission, Queen of Pain Prof Jennifer Abbey presented a harrowing case study of a resident with a gangrenous-looking foot. We’ll spare you the pic that was provided. The Adelaide professor of nursing...

09 Oct 2019 - Respiri (ASX:RSH) CEO Mario Gattino will be leaving the medical technology company.

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading. Stocks highlighted in yel...

Village Roadshow    Village Roadshow Limited (ASX: VRL) is a communication service sector company, which is registered in Australia. It is engaged in the operations of the theme park, water park, film distribution and film production. Today...